Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
2023 · Journal of Hematology & Oncology · 10 citations
https://doi.org/10.1186/s13045-023-01408-6
R
Renate S. Hagedoorn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
2.5K
Citations
24
h-index
38
i10-index
Renate S. Hagedoorn is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Immune Cell Function and Interaction. The author has an h-index of 24, co-authored 90 publications.
Papers by this author
worksAntibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells
2023 · Cancer Gene Therapy · 7 citations
https://doi.org/10.1038/s41417-023-00681-4
Mtb HLA-E-tetramer-sorted CD8+ T cells have a diverse TCR repertoire
2024 · iScience · 6 citations
https://doi.org/10.1016/j.isci.2024.109233
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia
2025 · Leukemia · 0 citations
https://doi.org/10.1038/s41375-025-02817-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat